Search Results - "vaccination"
Suggested Topics within your search.
Suggested Topics within your search.
- COVID-19 17
- COVID-19 (Disease) 17
- Coronavirus infections
- SARS-CoV-2 16
- Vaccination 14
- COVID-19 Vaccines 13
- Vaccines 12
- Development 11
- Betacoronavirus 10
- Coronavirus Infections 10
- prevention & control 10
- Research 9
- immunology 9
- Drug Development 7
- Coronaviruses 6
- virology 6
- Viral Vaccines 5
- drug effects 5
- Immunological aspects 4
- COVID-19 Pandemic, 2020- 3
- Communicable Diseases, Emerging 3
- Pandemics 3
- Spike Glycoprotein, Coronavirus 3
- administration & dosage 3
- drug therapy 3
- methods 3
- Clinical Trials as Topic 2
- Clinical trials 2
- Diagnosis 2
- Drug Design 2
-
1
SARS-COV-2 vaccine current biological targets and considerations /
Published 2020Table of Contents: “…Contents: Comparison of SARS-COV-2 with other coronavirus strains -- Targets for a SARS-COV-2 vaccine -- Other considerations once a vaccine has been developed.…”
Get full text
Series
Electronic Audio -
2
SARS-COV-2 vaccine development where are we now? /
Published 2020Table of Contents: “…Contents: Vaccine development for SARS-COV-2: Current position -- Different types of potential vaccines against COVID-19 -- New technologies and their implications -- How past experience can support current research.…”
Get full text
Series
Electronic Audio -
3
SARS-CoV-2 vaccine development
Published 2020Table of Contents: “…Contents: Current efforts to develop a vaccine -- Possible strategies for vaccine development -- Possible seasonal variations in virus prevalence -- When could a viable vaccine be expected?.…”
Get full text
Series
Electronic Audio -
4
The development of SARS-CoV-2 vaccines
Published 2020Table of Contents: “…Contents: Overview of three SARS-CoV-2 vaccines being developed -- Technologies being used -- Manufacturability -- Current stage of testing -- Next steps.…”
Get full text
Series
Electronic Audio -
5
mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals
Published 2021Table of Contents: “…Contents: Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection -- The efficacy of vaccines in previously infected vs previously uninfected individuals -- The efficacy of a single vs double dose -- The potential value of administrating a "booster" that is different from the previous administered vaccine in an individual, AKA "mixing-and-matching".…”
Get full text
Series
Electronic Audio -
6
Development of an intranasal vaccine for SARS-CoV-2
Published 2020Table of Contents: “…Contents: General mechanism of action of DNA vaccines -- Adenoviral vectors for DNA delivery to host cells -- Advantages and limitations of intranasal vaccines -- Cellular, mucosal and antibody immunity in the context of SARS-2 -- Stability of AdCOVID at room temperature -- Earliest possible approval of AdCOVID -- How far and how fast can this vaccine then be deployed?…”
Get full text
Series
Electronic Audio -
7
SARS-CoV-2 vaccine rollout campaigns
Published 2021Table of Contents: “…Contents: Overview on vaccine campaign strategies -- Challenges in a SARS-CoV-2 vaccine campaign strategy -- Identification of priority groups -- Difficulties of including priority groups into a vaccine campaign.…”
Get full text
Series
Electronic Audio -
8
Imperial College London's saRNA Vaccine - COVAC1
Published 2020Table of Contents: “…Contents: The self-amplifying RNA vaccine technology -- Current stage of the clinical trial -- Next steps in the clinical trial -- The future of the vaccine.…”
Get full text
Series
Electronic Audio -
9
Nanotechnologies in the fight against coronaviruses
Published 2020Table of Contents: “…Contents: The use of nanotechnologies in antiviral strategies, drugs, vaccines, and diagnostic tools -- Using nanotechnologies against human coronaviruses including SARS-CoV-2 -- Specific benefits of using nanotechnologies -- Carbon quantum dots.…”
Get full text
Series
Electronic Audio -
10
COVID-19 epidemiology and potential treatments follow up interview /
Published 2020Table of Contents: “…-- "Infectious dose" or "number of viruses" versus "viral load" -- Recent clinical trial results for SARS-2 treatments and vaccines -- Current clinical trials in Europe and the US.…”
Get full text
Series
Electronic Audio -
11
The paediatric response to the SARS-COV-2 virus and what we can learn from it
Published 2020Table of Contents: “…Contents: Current hypotheses on why children are less effected by COVID-19 than older individuals -- How this knowledge might benefit the treatment of older individuals -- Safety during related research -- The implications of this knowledge on vaccine development -- Future considerations for vaccine development.…”
Get full text
Series
Electronic Audio -
12
The current understanding of the biology of the SARS-COV-2 virus
Published 2020Table of Contents: “…Contents: Comparison between this new SARS-COV-2 strain and other coronavirus strains -- What information we are currently missing -- Steps in how to obtain required knowledge -- The current knowledge on methods of transmission -- A future view on therapies and vaccination.…”
Get full text
Series
Electronic Audio -
13
The immune system response to the SARS-COV-2 virus
Published 2020Subjects: Get full text
Series
Electronic Audio -
14
SARS-CoV-2 evolution within and between individuals
Published 2021Table of Contents: “…Contents: Evolutionary factors driving emergence of SARS-CoV-2 variants -- Metrics of SARS-CoV-2 infections: virus numbers per transmission event -- Potential co-infection with 2 or more variants per transmission event -- Current understanding of the origin and evolution of recent variants -- Impact of vaccines and treatments on evolutionary pressures of SAR-CoV-2.…”
Get full text
Series
Electronic Audio -
15
Genetic surveillance and the emergence of SARS-CoV-2 variants
Published 2021Subjects: Get full text
Series
Electronic Audio -
16
Poverty and the Impact of COVID-19 : The Blue-Marble Health Approach /
Published 2020Table of Contents: “…-- Introduction: COVID-19 and the Blue Marble -- China -- The United States of America -- The G20 -- A Framework for Science and Vaccine Diplomacy.…”
Full text available:
Electronic eBook -
17
Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers
Published 2020Table of Contents: “…Contents: The need to characterise SARS-CoV-2-specific T-cells from recovered patients -- Discovery of similar SARS-CoV-2-specific T-cells in healthy volunteers -- Possible reasons for presence of SARS-2-specific T-cells in healthy volunteers -- Differences in actions and behaviours of SARS-2-specific T-cells in patients versus volunteers -- Role of SARS-2-specific T-cells in conferring pre-existing immunity to COVID-19 (i.e. asymptomatic infections) -- Possible implications of the presence of such cells on disease progression -- Implications for vaccine development.…”
Get full text
Series
Electronic Audio